Selective blockade of D(3) dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate.

MLA

Silverdale, M. A., et al. “Selective Blockade of D(3) Dopamine Receptors Enhances the Anti-Parkinsonian Properties of Ropinirole and Levodopa in the MPTP-Lesioned Primate.” Experimental Neurology, vol. 188, no. 1, July 2004, pp. 128–38. EBSCOhost, https://doi.org/10.1016/j.expneurol.2004.03.022.

APA

Silverdale, M. A., Nicholson, S. L., Ravenscroft, P., Crossman, A. R., Millan, M. J., & Brotchie, J. M. (2004). Selective blockade of D(3) dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate. Experimental Neurology, 188(1), 128–138. https://doi.org/10.1016/j.expneurol.2004.03.022

Chicago

Silverdale, M A, S L Nicholson, P Ravenscroft, A R Crossman, M J Millan, and J M Brotchie. 2004. “Selective Blockade of D(3) Dopamine Receptors Enhances the Anti-Parkinsonian Properties of Ropinirole and Levodopa in the MPTP-Lesioned Primate.” Experimental Neurology 188 (1): 128–38. doi:10.1016/j.expneurol.2004.03.022.